Literature DB >> 22090103

Hepatitis C virus fails to activate NF-κB signaling in plasmacytoid dendritic cells.

Clélia Dental1, Jonathan Florentin, Besma Aouar, Francoise Gondois-Rey, David Durantel, Thomas F Baumert, Jacques A Nunes, Daniel Olive, Ivan Hirsch, Ruzena Stranska.   

Abstract

Plasmacytoid dendritic cells (pDCs) respond to viral infection by production of alpha interferon (IFN-α), proinflammatory cytokines, and cell differentiation. The elimination of hepatitis C virus (HCV) in more than 50% of chronically infected patients by treatment with IFN-α suggests that pDCs can play an important role in the control of HCV infection. pDCs exposed to HCV-infected hepatoma cells, in contrast to cell-free HCV virions, produce large amounts of IFN-α. To further investigate the molecular mechanism of HCV sensing, we studied whether exposure of pDCs to HCV-infected hepatoma cells activates, in parallel to interferon regulatory factor 7 (IRF7)-mediated production of IFN-α, nuclear factor kappa B (NF-κB)-dependent pDC responses, such as expression of the differentiation markers CD40, CCR7, CD86, and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and secretion of the proinflammatory cytokines TNF-α and interleukin 6 (IL-6). We demonstrate that exposure of pDCs to HCV-infected hepatoma cells surprisingly did not induce phosphorylation of NF-κB or cell surface expression of CD40, CCR7, CD86, or TRAIL or secretion of TNF-α and IL-6. In contrast, CpG-A and CpG-B induced production of TNF-α and IL-6 in pDCs exposed to the HCV-infected hepatoma cells, showing that cell-associated virus did not actively inhibit Toll-like receptor (TLR)-mediated NF-κB phosphorylation. Our results suggest that cell-associated HCV signals in pDCs via an endocytosis-dependent mechanism and IRF7 but not via the NF-κB pathway. In spite of IFN-α induction, cell-associated HCV does not induce a full functional response of pDCs. These findings contribute to the understanding of evasion of immune responses by HCV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22090103      PMCID: PMC3255840          DOI: 10.1128/JVI.05444-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

Authors:  Juliette Mouriès; Gabriel Moron; Géraldine Schlecht; Nicolas Escriou; Gilles Dadaglio; Claude Leclerc
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

2.  Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.

Authors:  Angela Meier; J Judy Chang; Ellen S Chan; Richard B Pollard; Harlyn K Sidhu; Smita Kulkarni; Tom Fang Wen; Robert J Lindsay; Liliana Orellana; Donna Mildvan; Suzane Bazner; Hendrik Streeck; Galit Alter; Jeffrey D Lifson; Mary Carrington; Ronald J Bosch; Gregory K Robbins; Marcus Altfeld
Journal:  Nat Med       Date:  2009-07-13       Impact factor: 53.440

3.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

4.  Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation.

Authors:  Heather W Stout-Delgado; Xin Yang; Wendy E Walker; Bethany M Tesar; Daniel R Goldstein
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

5.  Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function.

Authors:  Masaaki Shiina; Barbara Rehermann
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

6.  Interferon signaling and treatment outcome in chronic hepatitis C.

Authors:  Magdalena Sarasin-Filipowicz; Edward J Oakeley; Francois H T Duong; Verena Christen; Luigi Terracciano; Witold Filipowicz; Markus H Heim
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-08       Impact factor: 11.205

Review 7.  Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.

Authors:  Michel Gilliet; Wei Cao; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

8.  Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus.

Authors:  Hannah Phipps-Yonas; Jeremy Seto; Stuart C Sealfon; Thomas M Moran; Ana Fernandez-Sesma
Journal:  PLoS Pathog       Date:  2008-10-31       Impact factor: 6.823

9.  Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1.

Authors:  Françoise Gondois-Rey; Clélia Dental; Philippe Halfon; Thomas F Baumert; Daniel Olive; Ivan Hirsch
Journal:  PLoS One       Date:  2009-02-02       Impact factor: 3.240

10.  Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.

Authors:  Jérémie Decalf; Sandrine Fernandes; Randy Longman; Mina Ahloulay; Françoise Audat; François Lefrerre; Charles M Rice; Stanislas Pol; Matthew L Albert
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  16 in total

1.  NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.

Authors:  Yuwen Qin; Binbin Xue; Chunyan Liu; Xiaohong Wang; Renyun Tian; Qinya Xie; Mengmeng Guo; Guangdi Li; Darong Yang; Haizhen Zhu
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.

Authors:  B Dominguez-Molina; K Machmach; C Perales; L Tarancon-Diez; I Gallego; J L Sheldon; M Leal; E Domingo; E Ruiz-Mateos
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

3.  Chronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesis.

Authors:  Angela L Rasmussen; I-Ming Wang; Margaret C Shuhart; Sean C Proll; Yudong He; Razvan Cristescu; Chris Roberts; Victoria S Carter; Christopher M Williams; Deborah L Diamond; Janine T Bryan; Roger Ulrich; Marcus J Korth; Lisa V Thomassen; Michael G Katze
Journal:  Virology       Date:  2012-05-16       Impact factor: 3.616

4.  HCV core protein represses the apoptosis and improves the autophagy of human hepatocytes.

Authors:  Changhong Liu; Aihua Qu; Xiaochun Han; Yiguo Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 5.  The plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functions.

Authors:  Julien J Karrich; Loes C M Jachimowski; Christel H Uittenbogaart; Bianca Blom
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

Review 6.  Natural killer cells in hepatitis C: Current progress.

Authors:  Joo Chun Yoon; Chang Mo Yang; Youkyong Song; Jae Myun Lee
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity.

Authors:  Marlène Dreux; Urtzi Garaigorta; Bryan Boyd; Elodie Décembre; Josan Chung; Christina Whitten-Bauer; Stefan Wieland; Francis V Chisari
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

8.  HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells.

Authors:  Wei Chen; Yongfen Xu; Hua Li; Wanyin Tao; Yu Xiang; Bing Huang; Junqi Niu; Jin Zhong; Guangxun Meng
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

9.  Regulatory dendritic cells: there is more than just immune activation.

Authors:  Susanne V Schmidt; Andrea C Nino-Castro; Joachim L Schultze
Journal:  Front Immunol       Date:  2012-09-04       Impact factor: 7.561

10.  Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells.

Authors:  Besma Aouar; Denisa Kovarova; Sebastien Letard; Albert Font-Haro; Jonathan Florentin; Jan Weber; David Durantel; Laurence Chaperot; Joel Plumas; Katerina Trejbalova; Jiri Hejnar; Jacques A Nunès; Daniel Olive; Patrice Dubreuil; Ivan Hirsch; Ruzena Stranska
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.